trending Market Intelligence /marketintelligence/en/news-insights/trending/jg3peqir82xwlprb0d-lda2 content esgSubNav
In This List

CytoDyn raises $9.9M through private placement

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


CytoDyn raises $9.9M through private placement

Vancouver, Wash.-based CytoDyn Inc. raised approximately $9.9 million via the sale of 19,823,260 units at 50 cents apiece.

Each unit was made up of a common share and a warrant to purchase an additional stock at 75 cents each.

CytoDyn is developing treatments for HIV.